Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89251-89300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05424393
Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients
N/ARecruiting
500 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05304962
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
PHASE1Recruiting
64 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor8 locations
NCT04468360
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
PHASE2Recruiting
256 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT04977180
Cardioprotection in AML
PHASE2Recruiting
70 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2028
2 conditions1 sponsor1 location
NCT05273307
Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy
PHASE3Recruiting
40 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2026
2 conditions3 sponsors1 location
NCT05038592
Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
PHASE1/PHASE2Recruiting
64 participants
Started: Mar 4, 2022 · Completed: Jan 29, 2026
4 conditions1 sponsor1 location
NCT05024981
Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident
NARecruiting
64 participants
Started: Mar 4, 2022 · Completed: Jan 4, 2027
1 condition1 sponsor1 location
NCT05714111
Radiology Registry on Pancreatic Malignancies
N/ARecruiting
1,300 participants
Started: Mar 4, 2022 · Completed: Mar 30, 2030
4 conditions1 sponsor1 location
NCT05310734
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
PHASE4Recruiting
50 participants
Started: Mar 4, 2022 · Completed: Mar 31, 2026
1 condition6 sponsors3 locations
NCT05240885
Metabolic and Functional Consequences of Aging in Health and Disease
N/ARecruiting
100 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04645160
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
PHASE1/PHASE2Recruiting
31 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06327776
New Protein Biomarkers and Technology for Improving Diagnosis and Outcome Prediction in Mild TBI
N/ARecruiting
1,000 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05112991
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
PHASE2Recruiting
108 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor19 locations
NCT05238909
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
N/AEnrolling by invitation
200 participants
Started: Mar 4, 2022 · Completed: Jun 30, 2027
3 conditions3 sponsors1 location
NCT06075680
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases
NAActive, not recruiting
45 participants
Started: Mar 4, 2022 · Completed: Nov 30, 2023
3 conditions1 sponsor1 location
NCT05239845
Evaluating the Effects of Prebiotics on Sleep, the Gut Microbiome, Cognition, Immune Function and Stress
NAActive, not recruiting
68 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05410028
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
N/ARecruiting
1,000 participants
Started: Mar 3, 2022 · Completed: Mar 3, 2026
1 condition1 sponsor1 location
NCT05235659
EMPOWERYOU: Examining an Internet-based Prevention Program for Primary Caregivers
NARecruiting
317 participants
Started: Mar 3, 2022 · Completed: Jul 31, 2024
1 condition5 sponsors2 locations
NCT05189860
The C-MIC-II Follow-Up Study
NARecruiting
31 participants
Started: Mar 3, 2022 · Completed: Nov 15, 2026
1 condition1 sponsor6 locations
NCT05205850
A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
PHASE1/PHASE2Recruiting
135 participants
Started: Mar 3, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor2 locations
NCT05982912
VOC in Breath Samples for the Diagnosis of IPA
N/ARecruiting
200 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07131631
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
N/ARecruiting
125 participants
Started: Mar 3, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor6 locations
NCT05294042
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
NARecruiting
154 participants
Started: Mar 3, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05171244
Use of Immersive Virtual Reality to Train the Multisensory Processing Capacities of Children Aged 8 to 16 Years-old With an Autism Spectrum Disorder: Single-center Randomized Pilot Study in Parallel Groups - SEVIRE. (Sensory Virtual Reality)
NARecruiting
50 participants
Started: Mar 3, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT05329350
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
N/ARecruiting
100 participants
Started: Mar 3, 2022 · Completed: Oct 1, 2029
1 condition1 sponsor1 location
NCT04775706
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
PHASE2Recruiting
18 participants
Started: Mar 3, 2022 · Completed: May 31, 2028
1 condition1 sponsor13 locations
NCT05109429
Developing a Clinical Outcome Assessment for Opioid Craving
NARecruiting
81 participants
Started: Mar 3, 2022 · Completed: Sep 30, 2026
3 conditions2 sponsors1 location
NCT05036226
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
PHASE1/PHASE2Recruiting
76 participants
Started: Mar 3, 2022 · Completed: May 21, 2027
2 conditions1 sponsor1 location
NCT06242873
Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury
NARecruiting
20 participants
Started: Mar 3, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05152888
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
PHASE4Recruiting
50 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06143124
Bismuth Quadruple Therapy Versus Standard Triple Therapy
PHASE4Recruiting
216 participants
Started: Mar 3, 2022 · Completed: Nov 3, 2025
1 condition1 sponsor1 location
NCT04978584
Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
PHASE2Active, not recruiting
62 participants
Started: Mar 3, 2022 · Completed: Jan 16, 2027
1 condition1 sponsor1 location
NCT05805020
Cellvizio to Evaluate Margins in Crohn's Ileal Disease
NARecruiting
41 participants
Started: Mar 3, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05276596
Evaluation of the Early Use of Norepinephrine in Major Abdominal Surgery on Postoperative Organ Dysfunction
PHASE3Recruiting
500 participants
Started: Mar 3, 2022 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT05258656
Childhood Activities Nutrition and Development Oversight
NARecruiting
1,800 participants
Started: Mar 3, 2022 · Completed: Jun 30, 2028
1 condition2 sponsors2 locations
NCT05201014
Cancer Survivor Cardiomyopathy Detection
N/AActive, not recruiting
112 participants
Started: Mar 3, 2022 · Completed: Sep 20, 2026
2 conditions2 sponsors1 location
NCT05064358
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
177 participants
Started: Mar 3, 2022 · Completed: Jan 30, 2026
1 condition1 sponsor88 locations
NCT05106855
Comparative Study of Immediate Single Unit Implants in Early Loading Protocols, With or Without Photobiomodulation.
NARecruiting
60 participants
Started: Mar 3, 2022 · Completed: Dec 20, 2024
3 conditions1 sponsor1 location
NCT05301608
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 3, 2022 · Completed: Jun 9, 2026
1 condition1 sponsor1 location
NCT05369559
Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department
EARLY_PHASE1Recruiting
1,000 participants
Started: Mar 3, 2022 · Completed: May 22, 2025
1 condition1 sponsor2 locations
NCT05294120
A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
PHASE2Active, not recruiting
38 participants
Started: Mar 3, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors7 locations
NCT05223608
Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy
NARecruiting
500 participants
Started: Mar 3, 2022 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT05088863
Survey Assessing How Consumers Adapt Their Diet in Response to Health Claim Messaging
NARecruiting
384 participants
Started: Mar 3, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05286931
SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
NARecruiting
1,800 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05274022
Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture
NAActive, not recruiting
66 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05166655
DBS Recordings to Characterize Movement Facilitation in Parkinson's Disease
NARecruiting
40 participants
Started: Mar 3, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05062369
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
NARecruiting
40 participants
Started: Mar 3, 2022 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT05545332
Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
N/ARecruiting
600 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05064462
TTV Viral Load in Heart Transplant Recipients
N/AActive, not recruiting
60 participants
Started: Mar 3, 2022 · Completed: Mar 3, 2024
3 conditions2 sponsors3 locations
NCT05068102
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
PHASE1Recruiting
13 participants
Started: Mar 3, 2022 · Completed: May 31, 2026
3 conditions1 sponsor1 location